Purinomia Biotech is Drug Discovery in United States that focus on metabolic syndrome business. Founded in 2017. They cover business area such as developer, biological, cancer, autoimmunity, inflammatory disease, metabolic syndrome, therapy, treatment, small molecule compound, chemical synthesis, key ectonucleotidase, purinergic signaling.
2017
( 7 years old in 2024 )
Metabolic Syndrome
-
2- East Gill Street
Woburn, MA 01801
United States
Private
developerbiologicalcancerautoimmunityinflammatory diseasemetabolic syndrometherapytreatmentsmall molecule compoundchemical synthesiskey ectonucleotidasepurinergic signaling
* We use standard office opening hours in near Purinomia Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Purinomia Biotech is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Purinomia Biotech business is focusing on Metabolic Syndrome.
Purinomia Biotech headquarter office and corporate office address is located in 2- East Gill Street Woburn, MA 01801 United States.
Purinomia Biotech was founded in United States.
In 2024, Purinomia Biotech is currently focus on metabolic syndrome sector.
Above is snippet of Google Trends for "metabolic syndrome" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Purinomia Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
